30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

ARCH Venture Partners X, LLC

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
ARCH Venture Partners X, LLC's trades of Neumora Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-29 2025-10-27
B Purchase
86,923 +32.5%
447.28
US$4,952,632 		86,923 +32.5% 447.28 US$4,952,632
2025-08-01 2025-08-01
B Purchase
57,583 +44.9%
64.18
US$1,323,177 		57,583 +44.9% 64.18 US$1,323,177
2024-02-20 2024-02-15
B Purchase
41,224 +48.6%
139.68
US$1,151,018 		41,224 +48.6% 139.68 US$1,151,018
2023-09-20 2023-09-19
B Purchase
1,500,000 +70.6%
17.00
US$25,500,000 		1,500,000 +70.6% 17.00 US$25,500,000
2023-09-20 2023-09-19
B Purchase
1,500,000 +70.6%
17.00
US$25,500,000 		1,500,000 +70.6% 17.00 US$25,500,000
2022-10-26 2022-10-24
B Purchase
400,000 +7.0%
17.00
US$6,800,000 		400,000 +7.0% 17.00 US$6,800,000
2022-10-26 2022-10-24
B Purchase
400,000 +7.0%
17.00
US$6,800,000 		400,000 +7.0% 17.00 US$6,800,000
2019-02-26 2019-02-22
B Purchase
1,865,800 +inf%
2.50
US$4,664,500 		1,865,800 +inf% 2.50 US$4,664,500
2019-02-26 2019-02-22
B Purchase
150,000 +17.0%
2.50
US$375,000 		150,000 +17.0% 2.50 US$375,000
2019-02-26 2019-02-22
B Purchase
150,000 +5.5%
2.50
US$375,000 		150,000 +5.5% 2.50 US$375,000